Apollo Hospitals Enterprise (BOM:508869) Beneish M-Score: -2.46 (As of Jul. 03, 2026)


BOM:508869 Apollo Hospitals Enterprise Ltd BOM:508869
92 GF Score
Price ₹8,697.55
GF Value ₹8,723.27
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Apollo Hospitals Enterprise Beneish M-Score?

Apollo Hospitals Enterprise BOM:508869 +0.94% 92 Beneish M-Score is -2.46 as of Jul. 03, 2026. GuruFocus rates BOM:508869 with a GF Score™ of 92/100 and a GF Value™ of ₹8,723.27 (Fairly Valued). The stock has 4 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks worse than 60.86% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.46 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Apollo Hospitals Enterprise's Beneish M-Score or its related term are showing as below:

BOM:508869' s Beneish M-Score Range Over the Past 10 Years
Min: -2.94   Med: -2.59   Max: -2.3
Current: -2.46

During the past 13 years, the highest Beneish M-Score of Apollo Hospitals Enterprise was -2.30. The lowest was -2.94. And the median was -2.59.


Apollo Hospitals Enterprise Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Apollo Hospitals Enterprise's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apollo Hospitals Enterprise Beneish M-Score Chart

Apollo Hospitals Enterprise Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -2.46 -2.75 -2.32 -2.46

Apollo Hospitals Enterprise Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.32 0.00 0.00 0.00 -2.46

BOM:508869 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollo Hospitals Enterprise Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Apollo Hospitals Enterprise's Beneish M-Score falls into.


BOM:508869
92GF Score
Apollo Hospitals Enterprise Ltd BOM:508869
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apollo Hospitals Enterprise Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Apollo Hospitals Enterprise for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9443+0.528 * 0.9986+0.404 * 1.0523+0.892 * 1.1576+0.115 * 0.9706
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.041177-0.327 * 1.2023
=-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹36,735 Mil.
Revenue was ₹252,285 Mil.
Gross Profit was ₹121,529 Mil.
Total Current Assets was ₹68,998 Mil.
Total Assets was ₹221,969 Mil.
Property, Plant and Equipment(Net PPE) was ₹120,301 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹8,761 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹64,813 Mil.
Long-Term Debt & Capital Lease Obligation was ₹51,004 Mil.
Net Income was ₹19,417 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹28,557 Mil.
Total Receivables was ₹33,606 Mil.
Revenue was ₹217,940 Mil.
Gross Profit was ₹104,840 Mil.
Total Current Assets was ₹70,289 Mil.
Total Assets was ₹206,574 Mil.
Property, Plant and Equipment(Net PPE) was ₹107,391 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹7,575 Mil.
Selling, General, & Admin. Expense(SGA) was ₹26,855 Mil.
Total Current Liabilities was ₹45,789 Mil.
Long-Term Debt & Capital Lease Obligation was ₹43,858 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(36735 / 252285) / (33606 / 217940)
=0.145609 / 0.154198
=0.9443

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(104840 / 217940) / (121529 / 252285)
=0.48105 / 0.481713
=0.9986

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (68998 + 120301) / 221969) / (1 - (70289 + 107391) / 206574)
=0.147183 / 0.139872
=1.0523

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=252285 / 217940
=1.1576

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7575 / (7575 + 107391)) / (8761 / (8761 + 120301))
=0.065889 / 0.067882
=0.9706

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 252285) / (26855 / 217940)
=0 / 0.123222
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((51004 + 64813) / 221969) / ((43858 + 45789) / 206574)
=0.521771 / 0.43397
=1.2023

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(19417 - 0 - 28557) / 221969
=-0.041177

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Apollo Hospitals Enterprise has a M-score of -2.46 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.46 mean?
Apollo Hospitals Enterprise (BOM:508869) has a Beneish M-Score of -2.46 as of Jul. 03, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Apollo Hospitals Enterprise and its competitors. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #384 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 60.9%.
Is Apollo Hospitals Enterprise's Beneish M-Score too high?
Apollo Hospitals Enterprise's current Beneish M-Score is -2.46. Based on the distribution chart, Apollo Hospitals Enterprise ranks #384 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Apollo Hospitals Enterprise has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #384 out of 631 companies for Beneish M-Score. This places Apollo Hospitals Enterprise in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Apollo Hospitals Enterprise and its competitors. Apollo Hospitals Enterprise's current Beneish M-Score is -2.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,723.27, compared to a current price of ₹8,697.55 — trading 0.3% below its estimated fair value. The current Beneish M-Score is -2.46. Apollo Hospitals Enterprise's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Beneish M-Score is -2.46 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?

Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued. The current stock price of ₹8,697.55 is trading 0.3% below its estimated GF Value™ of ₹8,723.27. GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.

Key valuation signals for BOM:508869:

  • Beneish M-Score: -2.46
  • GF Value™: ₹8,723.27 vs. price of ₹8,697.55 (0.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Apollo Hospitals Enterprise Business Description

Other Exchanges APOLLOHOSP:India
Address No. 8-17, Shafee Mohammed Road, Sunny Side Building, East Block, 3rd Floor, Chennai, TN, IND, 600006
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
92GF Score

Get the complete analysis for BOM:508869

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8,697.55
Price
₹8,723.27
GF Value